Monitoring clusterin and fibrillar structures in aging and dementia
Objective: Clusterin is involved in a variety of physiological processes, including proteostasis. Several clusterin polymorphisms were associated with an increased risk of developing Alzheimer’s disease, the world-leading cause of dementia. Herein, the effect of a clusterin polymorphism, aging and d...
Main Authors: | Dário Trindade, Maria Cachide, Tânia Soares Martins, Sandra Guedes, Ilka M. Rosa, Odete A.B. da Cruz e Silva, Ana Gabriela Henriques |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-01-01
|
Series: | Aging Brain |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589958923000178 |
Similar Items
-
Plasma clusterin levels and risk of dementia, Alzheimer's disease, and stroke
by: Galit Weinstein, et al.
Published: (2016-01-01) -
The association of serum clusterin levels and Clusterin rs11136000 polymorphisms with Alzheimer disease in a Turkish cohort
by: Gamze Guven, et al.
Published: (2020-01-01) -
Clusterin ameliorates tau pathology in vivo by inhibiting fibril formation
by: Aleksandra M. Wojtas, et al.
Published: (2020-12-01) -
The clinical significance of plasma clusterin and Aβ in the longitudinal follow-up of patients with Alzheimer’s disease
by: Jung-Lung Hsu, et al.
Published: (2017-11-01) -
Genetic variation in clusterin and risk of dementia and ischemic vascular disease in the general population: cohort studies and meta-analyses of 362,338 individuals
by: Liv Tybjærg Nordestgaard, et al.
Published: (2018-03-01)